Document is current
Any future updates will be listed below
-
Authors
Herzig, Markus https://orcid.org/0000-0003-4435-7944
Eisenhofer, Simone https://orcid.org/0000-0001-7206-7384
Ruschkowski, Meike https://orcid.org/0000-0002-3858-5863
Neubert, Antje https://orcid.org/0000-0001-6575-1452
Bertsche, Astrid https://orcid.org/0000-0003-2832-0156
Bertsche, Thilo https://orcid.org/0000-0002-4930-6655
Neininger, Martina Patrizia https://orcid.org/0000-0002-5208-0888
-
Funding
Funding for this research was provided by:
Universität Leipzig
- License Information
-
More Information
Article History
Accepted: 27 February 2024
First Online: 31 March 2024
Declarations
:
: For this publication, no funding was received.
: Astrid Bertsche reports grants from UCB Pharma GmbH and honoraria for speaking engagements from Biogen GmbH, Desitin Arzneimittel GmbH, Eisai GmbH, GW Pharma GmbH, Neuraxpharm GmbH, Shire/Takeda GmbH, UCB Pharma GmbH, and ViroPharma GmbH. The other authors declare they have no conflicts of interest.
: Conceptualization: All authors. Investigation: Markus Herzig, Simone Eisenhofer, Meike Ruschkowski. Methodology: Simone Eisenhofer, Meike Ruschkowski, Martina Patrizia Neininger. Data curation: Markus Herzig. Formal analysis: Markus Herzig. Writing—original draft: Markus Herzig, Simone Eisenhofer, Martina Patrizia Neininger. Writing—review and editing: Meike Ruschkowski, Antje Neubert, Astrid Bertsche, Thilo Bertsche. Supervision: Martina Patrizia Neininger.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are available upon reasonable request.
